4//SEC Filing
SAMSON MARVIN 4
Accession 0001209191-20-003358
CIK 0001016169other
Filed
Jan 13, 7:00 PM ET
Accepted
Jan 14, 6:07 PM ET
Size
9.0 KB
Accession
0001209191-20-003358
Insider Transaction Report
Form 4
SAMSON MARVIN
Director
Transactions
- Exercise/Conversion
Common Stock
2020-01-10$2.66/sh+56$149→ 51,807 total - Sale
Common Stock
2020-01-10$4.50/sh−56$252→ 51,751 total - Exercise/Conversion
Stock Option (right to buy)
2020-01-10−56→ 0 totalExercise: $2.66From: 2018-06-07Exp: 2027-06-06→ Common Stock (56 underlying)
Footnotes (2)
- [F1]The stock option exercise and sale of common stock reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established in connection with estate planning and represents the remaining balance of a previously unexercised option grant to be transacted under the plan.
- [F2]The options vested and became exercisable in four quarterly installments over the one-year period following the grant date of June 7, 2017.
Documents
Issuer
ANTARES PHARMA, INC.
CIK 0001016169
Entity typeother
Related Parties
1- filerCIK 0000901056
Filing Metadata
- Form type
- 4
- Filed
- Jan 13, 7:00 PM ET
- Accepted
- Jan 14, 6:07 PM ET
- Size
- 9.0 KB